Sur-TCR-Tg transgenic mice express a T cell receptor recognizing surivin, a tumor-associated antigen, during early stages of thymopoiesis.
Crystal Mackall, Stanford University
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence) |
These transgenic mice express a T cell receptor (TCR) recognizing an immunodominant epitope of mouse Survivin (Sur20-28, a tumor-associated antigen (TAA)) during early stages of thymopoiesis. Spontaneous T-cell acute lymphoblastic leukemia (T-ALL) is reported to occur in 100% of Sur-TCR-Tg mice beginning at 4 months of age. T-ALL in Sur-TCR-Tg mice is characterized by enlargement of the spleen, thymus, lymph nodes, lung, liver, and kidney due to infiltration with sheets of terminal deoxynucleotidyl transferase (TdT)+ blasts. No phenotypic differences have been observed between hemizygotes and homozygotes. Both male and female transgenic mice are fertile. The transgene was integrated on mouse Chromosome 11, but copy number has not been determined.
The process of leukemogenesis observed in this model shows similarities with several other animal models of T-ALL, as well as T-ALL observed in patients treated with IL2Rγc-based gene therapy. In both this model and the clinical experience with IL2Rγc retroviral-based gene therapy, a receptor capable of providing a potent activation stimulus was expressed during the early stages of thymopoiesis and in both cases NOTCH1 mutations cooperated to generate full transformation. Although the issue of whether IL2Rγc expressed during early thymopoiesis can provide a leukemogenic signal is unresolved, several animal models have implicated the TCR as an oncogene in T-ALL. In some cases, TCR signaling during early thymopoiesis appears sufficient to induce T-ALL, whereas in others the TCR signals play a cooperating role as part of an oncogenic cascade. Pre-TCR signaling has also been implicated in T-ALL development as a cooperating event.
Tcra (Vα8/Jα24/Cα) and Tcrb (Vβ13/Dβ2/Jβ2/Cβ2) cDNAs were amplified from Sur20-28 tetramer binding CD8+ splenocytes and cloned into human CD2 minigene-based vectors. Sequence was introduced between (on the 5' end) the promoter, ATG-free first exon and first intron of the human CD2 gene and, on the 3' end ~500 bp of the 3' untranslated and flanking DNA of human CD2, including two polyadenylation signals and the 3' locus control region. The vectors were coinjected into fertilized C57BL/6N embryos. Resultant mice were maintained on a C57BL/6N background by the donating laboratory. The transgene was integrated on mouse Chromosome 11, but copy number has not been determined. This is founder line F8.
A 48 SNP (single nucleotide polymorphism) panel analysis, with 43 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, all 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were not on a C57BL/6N genetic background.
Expressed Gene | Tcrb, T cell receptor beta chain, mouse, laboratory |
---|---|
Expressed Gene | Tcra, T cell receptor alpha chain, mouse, laboratory |
Site of Expression |
Allele Name | transgene insertion F8, Crystal Mackall |
---|---|
Allele Type | Transgenic (Inserted expressed sequence) |
Allele Synonym(s) | Sur-TCR-Tg |
Gene Symbol and Name | Tg(CD2-Tcra,-Tcrb)F8Mack, transgene insertion F8, Crystal Mackall |
Gene Synonym(s) | |
Promoter | CD2, CD2 molecule, human |
Expressed Gene | Tcrb, T cell receptor beta chain, mouse, laboratory |
Expressed Gene | Tcra, T cell receptor alpha chain, mouse, laboratory |
Strain of Origin | C57BL/6 |
Chromosome | 11 |
Molecular Note | Tcra (Valpha8/Jalpha24/Calpha) and Tcrb (Vbeta13/Dbeta2/Jbeta2/Cbeta2) cDNAs were amplified from Sur20-28 tetramer binding CD8+ splenocytes and cloned into human CD2 minigene-based vectors. Sequence was introduced between (on the 5' end) the promoter, ATG-free first exon and first intron of the human CD2 gene and, on the 3' end ~500 bp of the 3' untranslated and flanking DNA of human CD2, including two polyadenylation signals and the 3' locus control region. The two vectors were coinjected and three founders (E8, F8, L8) with a high frequency of Sur20-28 tetramer-binding CD8+ T cells were selected. The F8 transgene integrated on mouse Chromosome 11. Mice express a TCR with specificity for murine Birc5 (survivin) peptide (20-28) presented by H2. |
Homozygotes and hemizygotes are viable, fertile.
When using the Sur-TCR-Tg mouse strain in a publication, please cite the originating article(s) and include JAX stock #028304 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(CD2-Tcra,-Tcrb)F8Mack |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.